RNAC - Cartesian Therapeutics, Inc.
6.75
-0.220 -3.259%
Share volume: 118,888
Last Updated: 04-24-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$6.97
-0.22
-0.03%
Summary score
42%
Profitability
50%
Dept financing
42%
Liquidity
58%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
19.19%
Return on assets
-6.18%
Return on sales
-1548.47%
Return on invested capital
34.89%
Total debt ratio
89.29%
Debt ratio change over timeo
-1.86%
Current Ratio
6.83%
Quick Ratio
4.37%
Cash Position Ratio
6.37%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-11.5%
Return on sales
-5568.42%
Return on invested capital
0%
Total debt ratio
114.55%
Debt ratio change over timeo
0%
Current Ratio
11.25%
Quick Ratio
0%
Cash Position Ratio
10.97%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-34.76%
Return on sales
-8304.01%
Return on invested capital
0%
Total debt ratio
142.59%
Debt ratio change over time
0%
Current Ratio
8.65%
Quick Ratio
0%
Cash Position Ratio
8.38%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-122%
Return on assets
-106.04%
Return on sales
-130.4%
Return on invested capital
-76.36%
Total debt ratio
-186.09%
Debt ratio change over time
-1.86%
Current Ratio
-5.66%
Quick Ratio
-4.52%
Cash Position Ratio
-4.91%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RNAC | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 19.19% | 12.23% | 10.41% | 0% |
| Return on assets | -6.18% | 4.74% | 3.19% | 1.73% |
| Return on sales | -1548.47% | 30.88% | 25.28% | 24.06% |
| Return on invested capital | 34.89% | 8.04% | 10.95% | 0% |
| Profitability | 50% | 72% | 59% | 29% |
| Total debt ratio | 89.29% | 80.37% | 59.38% | 94.09% |
| Debt ratio change over time | -1.86% | -20.57% | -85.61% | 17.33% |
| Dept financing | 24% | 21% | 16% | 50% |
| Current Ratio | 11.25% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 0% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 10.97% | 0.16% | 0.44% | 0.14% |
| Liquididy | 75% | 11% | 11% | 8% |
| Short-term ratios | RNAC | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -11.5% | 6.06% | 4.18% | 1.7% |
| Return on sales | -5568.42% | 39.61% | 26.91% | 24.78% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 34% | 23% |
| Total debt ratio | 114.55% | 80% | 59.26% | 100.88% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 17% | 13% | 22% |
| Current Ratio | 11.25% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 0% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 10.97% | 0.16% | 0.44% | 0.14% |
| Liquididy | 50% | 29% | 22% | 15% |